RAMM Pharma Corp., formerly MTC Growth Fund-I Inc. announces that on October 28, 2019 it completed its previously announced business combination with Medic Plast S.A. and Yurelan S.A., and the related acquisition of RAMM Pharma Holdings Corp. The common shares of the Company are expected to commence trading on the Canadian Securities Exchange under the symbol RAMM on November 8, 2019. Upon closing of the Transactions, the board of directors and management of the Company were reconstituted as follows in place of the previous directors and officers of MTC: Jackie Peter Burnett, Chief Executive Officer and a Director; Guillermo Delmonte, Chief Operating Officer; Matias Piñeiro, Chief Financial Officer; Dr. Armando Blankleider, Director; Daniel Augereau, Director; Eric Klein, Director; and Matthew Bajurny, Director.